Galiximab (Anti-CD28L / CD80)
A2559
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameGaliximab (Anti-CD28L / CD80)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionGaliximab (Anti-CD28L/CD80) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody targeting against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma. MW:145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203